Effect of a novel “emollient plus” formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients
European Journal of Dermatology · 2023-04 · 33 (2) · 137-146
DOI: 10.1684/ejd.2023.4449 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift European Journal of Dermatology, 2023-04. Verfasst von Aikaterini Patsatsi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Skin and Bullous Diseases Outpatient Unit of Papageorgiou General Hospital, 2nd Dermatology Department, School of Medicine, Faculty of Hea…. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Skin Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autoimmune Skin and Bullous Diseases Outpatient Unit of Papageorgiou General Hospital, 2nd Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, 541…
- First Department of Dermatology-Venereology, Aristotle University, State Hospital of Skin and Venereal Diseases, Thessaloniki, 541 24, Greece.
- Second Department of Dermatology-Venereology, Attikon University Hospital, Hospital of Skin and Venereal Diseases, Athens, 124 62, Greece.
- Department of Dermatology, University of Athens, Andreas Sygros Hospital, 161 21, Athens, Greece.
- Private Clinic, Argolidos 2, 115 23, Athens, Greece.
- Department of Dermatology, School of Medicine, University of Patras, Rio-Patras, 265 04, Greece.
Zitieren
APA
Patsatsi, A., Vakirlis, E., Kanelleas, A., Stefanaki, I., Kemanetzi, C., Loizidis, C., & Pasmatzi, E. (2023). Effect of a novel “emollient plus” formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients. European Journal of Dermatology, 33(2), 137-146. https://doi.org/10.1684/ejd.2023.4449
Vancouver
Patsatsi A, Vakirlis E, Kanelleas A, Stefanaki I, Kemanetzi C, Loizidis C, et al. Effect of a novel “emollient plus” formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients. European Journal of Dermatology. 2023;33(2):137-146. doi:10.1684/ejd.2023.4449
BibTeX
@article{Patsatsi2023,
author = {Patsatsi, Aikaterini and Vakirlis, Efstratios and Kanelleas, Antonios and Stefanaki, Irene and Kemanetzi, Christina and Loizidis, Christoforos and Pasmatzi, Efstathia},
title = {Effect of a novel “emollient plus” formulation on mild-to-severe atopic dermatitis and other dry skin-related diseases as monotherapy or adjunctive therapy: an observational study on efficacy, tolerance and quality of life in adult patients},
journal = {European Journal of Dermatology},
year = {2023},
volume = {33},
number = {2},
pages = {137--146},
doi = {10.1684/ejd.2023.4449}
}
EUVIMED